The GABA_A receptor delta (GABAA Rδ) subunit is integral to the function of GABAA receptors, which are pivotal in mediating the inhibitory neurotransmission in the central nervous system (CNS). The presence of the δ subunit is particularly associated with receptors located extrasynaptically, contributing to the tonic inhibitory conductance in various neurons. This form of inhibition is crucial for regulating neuronal excitability and maintaining the balance between excitatory and inhibitory signals within the CNS, playing a key role in processes such as sleep regulation, anxiety modulation, and seizure susceptibility. The GABAA Rδ-containing receptors are sensitive to low concentrations of GABA, the primary inhibitory neurotransmitter in the brain, allowing them to sustain a persistent inhibitory tone that modulates neuronal firing rates and network dynamics. The unique pharmacological profile of these receptors, including their insensitivity to classical benzodiazepines and differential responsiveness to neurosteroids and ethanol, underscores their distinct role in the neurophysiological processes and their potential as targets for specific pharmacological interventions.
The inhibition of GABAA Rδ-containing receptors can occur through various mechanisms, impacting the overall inhibitory tone and neuronal excitability. Direct inhibition may involve the binding of specific substances to the receptor, altering its conformation in a manner that reduces its affinity for GABA or impedes the opening of the associated chloride channel. This action directly decreases the receptor's ability to mediate inhibitory neurotransmission, affecting neuronal excitability and the balance of neural network activity. Indirect mechanisms of inhibition may involve alterations in receptor expression, trafficking, or localization, as well as modifications in the phosphorylation status of the receptor or associated proteins, impacting the efficiency of receptor insertion into the membrane or its functional capacity. Understanding the diverse mechanisms by which GABAA Rδ can be inhibited provides insight into the complex regulation of neuronal inhibition and the potential for targeting these processes in the modulation of CNS function.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Picrotoxin | 124-87-8 | sc-202765 sc-202765A sc-202765B | 1 g 5 g 25 g | $67.00 $286.00 $1326.00 | 11 | |
Antagonist inhibiting GABAA Rδ by binding to its chloride channel, preventing GABA-mediated hyperpolarization and neuronal inhibition. | ||||||
(+)-Bicuculline | 485-49-4 | sc-202498 sc-202498A | 50 mg 250 mg | $82.00 $281.00 | ||
Competitive antagonist blocking GABAA Rδ by binding to its receptor site, inhibiting GABAergic transmission and promoting excitability. | ||||||
Gabazine | 105538-73-6 | sc-211552 | 10 mg | $714.00 | 3 | |
Selective GABAA R antagonist interfering with the chloride channel, leading to reduced inhibitory neurotransmission and increased neuronal activity. | ||||||
Furosemide | 54-31-9 | sc-203961 | 50 mg | $41.00 | ||
Loop diuretic indirectly inhibiting GABAA Rδ by modulating intracellular chloride concentrations, disrupting GABAergic signaling. | ||||||
Zinc | 7440-66-6 | sc-213177 | 100 g | $48.00 | ||
Modulates GABAA Rδ function by interacting with the receptor complex, influencing channel conductance and GABA sensitivity. | ||||||
Flumazenil (Ro 15-1788) | 78755-81-4 | sc-200161 sc-200161A | 25 mg 100 mg | $110.00 $370.00 | 10 | |
Competitive antagonist at the benzodiazepine binding site on GABAA Rs, indirectly modulating GABAA Rδ activity and inhibitory neurotransmission. | ||||||
DHEA | 53-43-0 | sc-202573 | 10 g | $111.00 | 3 | |
Neurosteroid modulating GABAA Rδ activity by binding to specific sites, influencing receptor sensitivity and promoting GABAergic inhibition. | ||||||